Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,848,246
Closed -$16.1M 26
2021
Q3
$16.1M Sell
5,848,246
-603,381
-9% -$1.91M 1.71% 6
2021
Q2
$22.2M Sell
6,451,627
-729,725
-10% -$2.37M 2.31% 6
2021
Q1
$19.7M Buy
7,181,352
+1,371,516
+24% +$3.87M 2.25% 6
2020
Q4
$17.8M Buy
5,809,836
+234,006
+4% +$631K 1.86% 6
2020
Q3
$13.8M Buy
5,575,830
+212,679
+4% +$533K 1.6% 6
2020
Q2
$14.2M Buy
5,363,151
+973,415
+22% +$2.3M 2.12% 7
2020
Q1
$10.1M Buy
4,389,736
+1,320,239
+43% +$4.78M 2.06% 7
2019
Q4
$14.3M Buy
3,069,497
+347,321
+13% +$1.54M 2.29% 7
2019
Q3
$12.6M Buy
2,722,176
+178,544
+7% +$855K 2.22% 8
2019
Q2
$11.9M Buy
2,543,632
+403,673
+19% +$1.81M 2.16% 8
2019
Q1
$9.2M Buy
2,139,959
+2,077
+0.1% +$9.54K 1.88% 8
2018
Q4
$8.38M Buy
+2,137,882
New +$9.13M 2% 8

Other funds holding ABEV

Northcape Capital's ABEV Position: Q4 2021 in Review

Northcape Capital sold out of Ambev (ABEV) in Q4 2021, closing a stake of 5,848,246 shares — an estimated $16.1M sold.

Northcape Capital first reported a position in ABEV in Q4 2018 and held it in 12 quarters. The position peaked at $22.2M in Q2 2021. 284 funds tracked by Wall St. Rank hold ABEV as of Q4 2021.

  • Northcape Capital reported no remaining Ambev position as of Q4 2021 after selling out during the quarter.
  • Northcape Capital sold 5,848,246 Ambev shares in Q4 2021, an estimated $16.1M.
  • Northcape Capital first reported a position in Ambev in Q4 2018 and held it in 12 quarters.
  • Northcape Capital's Ambev position peaked at $22.2M in Q2 2021.
  • 284 funds tracked by Wall St. Rank held Ambev as of Q4 2021.

Based on Northcape Capital's 13F filing for Q4 2021, filed 11 Feb 2022.